BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28796556)

  • 21. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.
    Taguchi S; Fukuhara H; Todo T
    Jpn J Clin Oncol; 2019 Mar; 49(3):201-209. PubMed ID: 30462296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies.
    Ekeke CN; Russell KL; Joubert K; Bartlett DL; Luketich JD; Soloff AC; Guo ZS; Lotze MT; Dhupar R
    Ann Surg Oncol; 2021 May; 28(5):2715-2727. PubMed ID: 33575873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic viruses: From bench to bedside with a focus on safety.
    Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
    Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.
    Sam M; Selman M; Zhao W; Jung J; Willingham A; Phan U; Starling GC; Gao Q
    J Virol; 2023 May; 97(5):e0030923. PubMed ID: 37070982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Advances of Oncolytic Herpes Simplex Virus in Cancer Therapy].
    Hao M; Huang C; Xia N
    Bing Du Xue Bao; 2016 Jul; 32(4):516-22. PubMed ID: 29996042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic virotherapies for pediatric tumors.
    Gross EG; Hamo MA; Estevez-Ordonez D; Laskay NM; Atchley TJ; Johnston JM; Markert JM
    Expert Opin Biol Ther; 2023; 23(10):987-1003. PubMed ID: 37749907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
    Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
    Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
    Kaur B; Chiocca EA; Cripe TP
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1842-51. PubMed ID: 21740359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of disseminated cancer after systemic oncolytic virotherapy.
    Russell SJ; Federspiel MJ; Peng KW; Tong C; Dingli D; Morice WG; Lowe V; O'Connor MK; Kyle RA; Leung N; Buadi FK; Rajkumar SV; Gertz MA; Lacy MQ; Dispenzieri A
    Mayo Clin Proc; 2014 Jul; 89(7):926-33. PubMed ID: 24835528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.
    Au GG; Lincz LF; Enno A; Shafren DR
    Br J Haematol; 2007 Apr; 137(2):133-41. PubMed ID: 17391493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma.
    Stewart G; Chantry A; Lawson M
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.
    Peng KW; Dogan A; Vrana J; Liu C; Ong HT; Kumar S; Dispenzieri A; Dietz AB; Russell SJ
    Am J Hematol; 2009 Jul; 84(7):401-7. PubMed ID: 19507209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curative one-shot systemic virotherapy in murine myeloma.
    Naik S; Nace R; Federspiel MJ; Barber GN; Peng KW; Russell SJ
    Leukemia; 2012 Aug; 26(8):1870-8. PubMed ID: 22425894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma.
    Lei W; Wang S; Yang C; Huang X; Chen Z; He W; Shen J; Liu X; Qian W
    Sci Rep; 2016 Aug; 6():32174. PubMed ID: 27552933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical.
    Tang C; Li L; Mo T; Na J; Qian Z; Fan D; Sun X; Yao M; Pan L; Huang Y; Zhong L
    Clin Transl Oncol; 2022 Sep; 24(9):1682-1701. PubMed ID: 35612653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taming measles virus to create an effective cancer therapeutic.
    Bell JC
    Mayo Clin Proc; 2014 Jul; 89(7):863-5. PubMed ID: 24835529
    [No Abstract]   [Full Text] [Related]  

  • 39. Viruses in cancer treatment.
    Alemany R
    Clin Transl Oncol; 2013 Mar; 15(3):182-8. PubMed ID: 23143950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential and clinical translation of oncolytic measles viruses.
    Robinson S; Galanis E
    Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.